[Edaily Reporter Hyera Lee ] The KOSDAQ Market Division of the Korea Exchange announced on the 8th that it will lift the trading suspension on common shares of NGeneBio Co., Ltd.(354200) starting on the 13th. The resumption of trading follows a change in the stock listing resulting from a stock split.
Disclosure Plus
Stock Exchange to Lift Trading Suspension on Shares of NGeneBio Co., Ltd. on the 13th
Economy
Corporation
IT·Science
Economy
'Largest Bitcoin ETF' BlackRock's IBIT Sees 'Record-High' Net Outflows Amid Anthropic IPO
Just before Anthropic, the U.S. artificial intelligence (AI) developer behind “Clod,” went public on the Nasdaq, the iShares Bitcoin Trust (IBIT)—BlackRock’s iShares Bitcoin Trust, the largest Bitcoin…
Corporation
Celltrion Sees Full-Scale Results from Direct Sales in the U.S. … “Projected Operating Profit of 2.4 Trillion Won Next Year”
Celltrion(068270)Forecasts indicate that Celltrion will continue its steep earnings growth as it expands its direct sales performance in the U.S. biosimilar market. Expectations for a revaluation of t…
IT·Science
Penetrium Bioscience and AprilBio Rally as AriBio-Linked Stocks Diverge [K-Bio Pulse]
South Korean pharmaceutical and biotechnology stocks posted mixed results on November 19, driven by clinical trial developments and expectations regarding their inclusion in major stock indices. Penet…